Venture Capital For Life Sciences Cools Off In 2022
Venture capital funding in the U.S. life sciences sector declined by 28.2% in 2022 amid economic headwinds, according to a Wednesday report from Savills Research and Data Services....To view the full article, register now.
Already a subscriber? Click here to view full article